This project is part of the international Decision Support Initiative (iDSI), an innovative global partnership between leading government institutions, universities, and think tanks in the field of healthcare priority-setting. iDSI uniquely provides intellectual insight with hands-on field expertise, and delivers peer-to-peer support to policymaker

The Prince Mahidol Award Conference (PMAC) is an annual international conference focusing on policy-related health issues. PMAC is co-hosted by the Prince Mahidol Award Foundation with support from other key related partners. In 2021, HITAP has led one webinar session and co-led two others with international partners. For more information, please v

Jarawee Sukmanee is a researcher at the Health Intervention and Technology Assessment Program Foundation (HITAP). With a background as a medical doctor and epidemiologist, she applies advanced analytical techniques to evaluate the cost-effectiveness of health interventions. She plays a key role in generating evidence to support national policy deci

Abstract Background Due to competing health priorities and limited resources, many low-income countries, even those with a high disease burden, are not able to introduce pneumococcal conjugate vaccines. Objective To determine the cost-utility of 10- and 13-valent pneumococcal conjugate vacci

ABSTRACT There has been continuous development in the field of health technology assessment (HTA) owing to the added value of HTA in supporting healthcare reimbursement decisions. Collaboration and engagement among countries in Asia has been carried out to share experiences and learning on the ba

Abstract Planning and administering Universal Health Coverage (UHC) policies involve complex and critical decisions, especially in resource-scarce and densely populated settings such as Indonesia. Increasing investments alone do not ensure success and sustainability of UHC, and defining prioritie

Doctors were told last month that we should stop doing so many screenings for prostate cancer with the prostate-specific antigen test. We learned that sigmoidoscopy is a cheaper, easier and effective alternative to colonoscopy for colon cancer screening. And a study I led turned up strong evidence t

Senegalese delegation with Dr. Yot Teerawattananon, Dr. Wanrudee Isaranuwatchai and Aparna Ananthakrishnan from HITAP We are very honored to have participated in the Health Technology Assessment (HTA) training and symposium.We have seen interestin

Breast cancer screening saves the lives of two women for every one patient who receives unnecessary treatment, according to a major European review.There has been a fierce debate about the use of screening, and policy is being reviewed in England.The latest study, published in the Journal of Medical

Abstract Surrogate endpoints are frequently used as primary outcomes in clinical trials. This is appropriate when they are validated for their ability to predict clinical benefit measured on patient-relevant target outcome(s). Such validation is often lacking, thus increasing uncertainty in the dec